Skip to main navigation Skip to search Skip to main content

A 24 month, multicenter, randomized, open-label safety and efficacy study of concentration-controlled everolimus with reduced calcineurin inhibitor vs mycophenolate with standard calcineurin inhibitor in de novo renal transplantation-

    Project: Research

    Project Details

    StatusActive
    Effective start/end date03/1/15 → …